Trends in Euphorbia hirta Research: A 30-year Bibliometric Appraisal of the Present Realities

IF 0.6
I. Elisha, J. Gotep, M. Makoshi, J. Usman, Blessing Shok, K. Oyebade, Z. Muhammad, Itodo Akogwu, K. Tondo, Hong Joseph, Edirin Akpojosevbe, B. Yakubu, Maryam Division, N. Vom, Plateau Stat
{"title":"Trends in Euphorbia hirta Research: A 30-year Bibliometric Appraisal of the Present Realities","authors":"I. Elisha, J. Gotep, M. Makoshi, J. Usman, Blessing Shok, K. Oyebade, Z. Muhammad, Itodo Akogwu, K. Tondo, Hong Joseph, Edirin Akpojosevbe, B. Yakubu, Maryam Division, N. Vom, Plateau Stat","doi":"10.5455/jcmr.2023.14.01.16","DOIUrl":null,"url":null,"abstract":"Euphorbia hirta L.. is a common herb with global spread. Different parts of E. hirta are used in traditional medicine for the treatment of a variety of human and animal conditions, such as skin diseases, inflammation, digestive and respiratory disorders. This bibliometric study aimed to provide a panoramic view of the publication landscape in the last thirty years of Euphorbia hirta research. VOSviewer was used to analyze 603 documents retrieved from Scopus database during the period, 1992 to 2021. Dominant research themes in the last thirty years were centred on the application of crude extracts or isolated compounds from E. hirta against diabetes, oxidative stress, inflammation, tuberculosis, snake bite, gastro-intestinal disorders, respiratory infections, skin pathologies, bacterial, fungal and viral infections. Current paradigm shift in E. hirta research are targeted at improving the efficacy of phytomolecules against resistant bacterial pathogens and cancer cells via green synthesis of nanoparticles and the application of in silico technologies in predicting the activities of nano-phytomolecules against SARS-CoV-2 and the dengue virus. This study recommends further research in the determination of the bioavailability of molecules in in vivo models. Researchers should carry out more preclinical investigations with the aim of establishing the pharmacokinetic and pharmacodynamic properties of phytocompounds instead of relying solely on in silico predictions.","PeriodicalId":41505,"journal":{"name":"Journal of Complementary Medicine Research","volume":null,"pages":null},"PeriodicalIF":0.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Complementary Medicine Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/jcmr.2023.14.01.16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Euphorbia hirta L.. is a common herb with global spread. Different parts of E. hirta are used in traditional medicine for the treatment of a variety of human and animal conditions, such as skin diseases, inflammation, digestive and respiratory disorders. This bibliometric study aimed to provide a panoramic view of the publication landscape in the last thirty years of Euphorbia hirta research. VOSviewer was used to analyze 603 documents retrieved from Scopus database during the period, 1992 to 2021. Dominant research themes in the last thirty years were centred on the application of crude extracts or isolated compounds from E. hirta against diabetes, oxidative stress, inflammation, tuberculosis, snake bite, gastro-intestinal disorders, respiratory infections, skin pathologies, bacterial, fungal and viral infections. Current paradigm shift in E. hirta research are targeted at improving the efficacy of phytomolecules against resistant bacterial pathogens and cancer cells via green synthesis of nanoparticles and the application of in silico technologies in predicting the activities of nano-phytomolecules against SARS-CoV-2 and the dengue virus. This study recommends further research in the determination of the bioavailability of molecules in in vivo models. Researchers should carry out more preclinical investigations with the aim of establishing the pharmacokinetic and pharmacodynamic properties of phytocompounds instead of relying solely on in silico predictions.
大戟研究的趋势:对当前现实的30年文献计量学评价
大戟hirta L..是一种常见的草本植物,遍布全球。hirta的不同部分在传统医学中用于治疗各种人类和动物疾病,如皮肤病、炎症、消化和呼吸系统疾病。本文献计量学研究旨在提供近三十年大戟研究的出版景观全景视图。使用VOSviewer对1992 ~ 2021年Scopus数据库检索的603篇文献进行分析。在过去的三十年中,主要的研究主题集中在应用hirta的粗提取物或分离化合物来治疗糖尿病、氧化应激、炎症、肺结核、蛇咬伤、胃肠道疾病、呼吸道感染、皮肤病变、细菌、真菌和病毒感染。目前,hirta研究的范式转变旨在通过纳米颗粒的绿色合成和应用硅技术预测纳米植物分子对SARS-CoV-2和登革热病毒的活性,提高植物分子对耐药细菌病原体和癌细胞的功效。本研究建议进一步研究确定分子在体内模型中的生物利用度。研究人员应该开展更多的临床前研究,目的是建立植物化合物的药代动力学和药效学特性,而不是仅仅依靠计算机预测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
16.70%
发文量
0
期刊介绍: Journal of Intercultural Ethnopharmacology (2146-8397) Between (2012 Volume 1, Issue 1 - 2018 Volume 7, Issue 1). Journal of Complementary Medicine Research is aimed to serve a contemporary approach to the knowledge about world-wide usage of complementary medicine and their empirical and evidence-based effects. ISSN: 2577-5669
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信